TRDA - Entrada Therapeutics
TRDA is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
Yes - one large investor is pushing for changes at this company.
- MPM BioVentures 2014, L.P. owns 9.9% and has said it may push for changes. Since Sept 10, 2026.
What this means for you
MPM BioVentures 2014, L.P. has told the regulator it may push for changes at this company. That usually means asking for a seat on the board, a sale of the company, or a change in how it is run.
Nothing is required of you now.
Large investors can also sell down and walk away. We show every notice they file, the day it is filed.
What happened, and when
-
Sept 10, 2026
MPM BioVentures 2014, L.P. now owns 9.9%. It has said it may push for changes.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| Sept 10, 2026 | MPM BioVentures 2014, L.P. | 9.9% | Updated notice |
No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- Nasdaq
See this fund's page at the SEC →
Email me when something new is filed for TRDA
Free. One email per notice or announcement, usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.